Review
The authors provide an updated and comprehensive summary of the latest advancements in the quest for compounds targeting EGFR-mutant advanced non-small-cell lung cancer, discussing the biological rationale underlying the development of a forefront combination of TKI and/or new antibody–drug conjugates.
Review
In this narrative review, the authors summarize the use of aromatics for the symptomatic relief of upper respiratory tract infections and how this affects sleep quality.
Review
The authors provide a concise but comprehensive summary of the challenges that lie ahead as we move towards personalized treatment of Ex20ins-mutant and HER2-mutant advanced NSCLC, also suggesting a treatment algorithm that could be followed for patients with these genetic aberrations.
Commentary
This article aims to provide contextual information for a general audience interested in conducting or evaluating cost-of-illness studies that may include drug costs and to describe key factors to consider when reviewing drug costs in the peer-reviewed literature.
Corrigendum
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
